Abiopharma

QUIDELORTHO CORP (QDEL)

Symbol	QDEL
Name	QUIDELORTHO CORP
Sector	HEALTH CARE
Region	North America
Industry	In Vitro & In Vivo Diagnostic Substances
Address	9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA 92121
Telephone	(858) 552-1100
Fax	—
Email	—
Website	https://www.quidelortho.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001906324
Description	QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. Additional info from NASDAQ: QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.

2026-07-02 20:06

Hanson Bryan Michael 🟡 adjusted position in 2.1K shares (1 derivative) of QuidelOrtho Corp (QDEL) at $18.18 Transaction Date: Jul 01, 2026 | Filing ID: 000009

2026-06-29 22:01

Director WIDDER KENNETH J 🟢 acquired 24.2K shares (3 derivative) of QuidelOrtho Corp (QDEL) Transaction Date: Jun 25, 2026 | Filing ID: 000006

2026-06-29 22:00

Director Huennekens R Scott 🟢 acquired 15.5K shares (1 derivative) of QuidelOrtho Corp (QDEL) Transaction Date: Jun 25, 2026 | Filing ID: 000008

2026-06-29 22:00

Director Chiminski John R 🟢 acquired 22.2K shares (3 derivative) of QuidelOrtho Corp (QDEL) Transaction Date: Jun 25, 2026 | Filing ID: 000003

2026-06-29 21:59

Director Wilkins Joseph D Jr. 🟢 acquired 15.5K shares (1 derivative) of QuidelOrtho Corp (QDEL) Transaction Date: Jun 25, 2026 | Filing ID: 000003

2026-06-29 21:59

Director RHOADS ANN D 🟢 acquired 19.6K shares (3 derivative) of QuidelOrtho Corp (QDEL) Transaction Date: Jun 25, 2026 | Filing ID: 000007

2026-06-29 21:59

Director POLAN MARY LAKE PH D 🟢 acquired 22.7K shares (3 derivative) of QuidelOrtho Corp (QDEL) Transaction Date: Jun 25, 2026 | Filing ID: 000005

2026-06-29 21:58

Director Michael Edward L. 🟢 acquired 20.1K shares (3 derivative) of QuidelOrtho Corp (QDEL) Transaction Date: Jun 25, 2026 | Filing ID: 000005

2026-06-29 21:57

Director Dilsaver Evelyn S 🟢 acquired 15.5K shares (1 derivative) of QuidelOrtho Corp (QDEL) Transaction Date: Jun 25, 2026 | Filing ID: 000010

2026-06-29 21:56

Director BUECHLER KENNETH F 🟢 acquired 31.4K shares (3 derivative) of QuidelOrtho Corp (QDEL) Transaction Date: Jun 25, 2026 | Filing ID: 000005

Trial ID	Title	Phase	Indication	Status	Start Date	Completion Date	Source
NCT05322395	Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway	Na	Acute Coronary Syndrome	Unknown	2021-12-10	2024-11-10	ClinicalTrials.gov
NCT03813966	Nasal Swab Home Collection Kit (NSHC Kit) Study	—	Influenza Viral Infections	Completed	2019-02-07	2020-06-30	ClinicalTrials.gov
NCT03238274	Sofia 2 Lyme FIA Whole Blood Clinical Study	—	Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)	Completed	2017-06-06	2017-12-15	ClinicalTrials.gov
NCT03417869	QuickVue Influenza A + B Test Field Study	—	Influenza A, Influenza B	Completed	2017-02-16	2018-02-01	ClinicalTrials.gov
NCT02566447	"Solana™ Trichomonas Assay Field Study"	—	Trichomonas Vaginalis	Completed	2015-10-15	2016-08-15	ClinicalTrials.gov
NCT03099018	Comparison of Two Rapid Antigen Detection Tests for the Detection of Group-A St…	—	Pharyngitis	Completed	2014-06-01	2016-11-01	ClinicalTrials.gov
NCT02153008	Strep A FIA Field Study, Sofia	—	Group A Streptococcus	Completed	2014-04-01	2016-07-01	ClinicalTrials.gov
NCT01803113	Sofia hCG FIA Field Study	—	Pregnancy, Early Detection	Completed	2013-01-01	2013-03-01	ClinicalTrials.gov
NCT01734668	Sofia RSV FIA Field Study	—	Respiratory Syncytial Virus	Completed	2012-03-01	2013-01-01	ClinicalTrials.gov
NCT01494792	Sofia Strep A FIA Field Study	—	Group A Streptococcus	Terminated	2011-11-01	2012-08-01	ClinicalTrials.gov
NCT01441479	Strep A Fluorescent Immunoassay and Analyzer Field Study	—	Strep Throat	Completed	2011-06-01	2012-12-01	ClinicalTrials.gov
NCT01309568	"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"	—	Influenza	Completed	2011-02-01	2011-04-01	ClinicalTrials.gov
NCT00491283	QuickVue Influenza A+B Clinical Field Trial	Na	Influenza	Completed	2006-07-01	2006-08-01	ClinicalTrials.gov

Total clinical trials: 13

Product Name	Type	Development Stage	Therapeutic Area	Study Status	Trial ID
Swab Specimen Collection (QuickVue)	Other	Approved	Influenza	COMPLETED	NCT00491283
In Vitro Diagnositc aid for diagnosis	Other	Preclinical	Group A Streptococcus	TERMINATED	NCT01494792
In Vitro Diagnositc aid for diagnosis	Other	Preclinical	Group A Streptococcus	TERMINATED	NCT01494792
In Vitro Diagnostic device to aid in diagnosis	Device	Preclinical	Respiratory Syncytial Virus	COMPLETED	NCT01734668
In Vitro Diagnostic device to aid in diagnosis	Device	Preclinical	Respiratory Syncytial Virus	COMPLETED	NCT01734668
In Vitro Diagnostic Device aid in diagnosing	Device	Preclinical	Strep Throat	COMPLETED	NCT01441479
In Vitro Diagnostic Device aid in diagnosing	Device	Preclinical	Strep Throat	COMPLETED	NCT01441479
Sofia hCG FIA	Other	Preclinical	Pregnancy, Early Detection	COMPLETED	NCT01803113
Sofia hCG FIA	Other	Preclinical	Pregnancy, Early Detection	COMPLETED	NCT01803113
Sofia Strep A FIA	Other	Preclinical	Pharyngitis	COMPLETED	NCT03099018
Sofia Strep A FIA	Other	Preclinical	Pharyngitis	COMPLETED	NCT03099018
QuickVue Influenza A+B	Other	Preclinical	Influenza A, Influenza B	COMPLETED	NCT03417869
QuickVue Influenza A+B	Other	Preclinical	Influenza A, Influenza B	COMPLETED	NCT03417869
Sofia 2 Lyme FIA testing	Other	Preclinical	Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)	COMPLETED	NCT03238274
Sofia 2 Lyme FIA testing	Other	Preclinical	Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)	COMPLETED	NCT03238274
Solana Trichomonas Assay Testing	Other	Preclinical	Trichomonas Vaginalis	COMPLETED	NCT02566447
Sofia Influenza A+B FIA	Other	Preclinical	Influenza Viral Infections	COMPLETED	NCT03813966

Total products: 17